Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

WELCURE DRUGS & PHARMACEUTICALS LTD.

  • NSE Code-
  • BSE Code524661
  • ISININE331C01025
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

06/08/1996

Registered Address

Registered Office : Plot No. 55, Office No- 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi,
New Delhi, Delhi - 110092

Registrar Office

Skyline Financial Services (p) Ltd.
D-153/A,1st Floor,Okhla Industrial Area, Phase-1
New Delhi,110020,Delhi
Tel: 011-26292682
Fax: 30857562

Email

welcuredrugs227@gmail.com

Website

https://welcure.co.in

Listing

BSE

Corporate News

Welcure Drug&Pharma. - Audited Standalone Financial R...

29-May-2026|8:09PM

Audited Standalone Financial Results for the Quarter and Year Ended 31st Ma

Welcure Drug&Pharma. - Board Meeting Outcome for Outc...

29-May-2026|8:01PM

Outcome of the Meeting of Board of Directors of the Company held on today i

Welcure Drug&Pharma. - Board Meeting Intimation for C...

22-May-2026|4:48PM

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the

Welcure Drug&Pharma. - Format of the Initial Disclosu...

23-Apr-2026|11:54AM

Format of Initial Disclosure to be made by an entity identified as a Lar

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.99221.14
Aarti Drug380.403,471.91
Aarti Pharma633.255,740.90
Abbott India26,855.0057,065.00
Accent Micro441.951,060.19
More

MF Holding

No Data Available

Board Meetings

DatePurpose
29/05/2026Audited Results
12/02/2026Quarterly Results
05/12/2025Right Issue of Equity S..
27/11/2025To consider raisinf of ..
13/11/2025Quarterly Results
More
Attention Investors "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." |  "Prevent Unauthorized Transactions in your Demat Account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account directly from CDSL on the same day......................issued in the interest of investors." |  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."  |  "Filing compliant on SCORES – Easy & quick -- a. Register on SCORES portal -- b. Mandatory details for filing complaints on SCORES --I. Name, PAN, Address, Mobile Number, E-mail ID – c. Benefits: -- i. Effective Communication -- ii. Speedy redressal of the grievances." |  Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. |  |Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. |  | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"
CIN : U67120MH1994PLC079199 BSE SEBI REGN No.: INZ000199833, CD-189 (MEMBER ID:189) | NSE SEBI REGN No.:INZ000199833(MemberID:07277) | CDSL DP SEBI REGN No.:IN-DP-102-2015(DP ID:18600) | SEBI PMS REGN No.:INP000005795 | SEBI RESEARCH ANALYST REGN No.:INH000001337  | AMFI : ARN 0342.
Copyright © 2019 SRE. All rights reserved.
Designed , Developed & Content Powered by DION